These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 33928773)

  • 1. Deep vein thrombosis more than two weeks after vaccination against COVID-19.
    Haakonsen HB; Nystedt A
    Tidsskr Nor Laegeforen; 2021 Apr; 141():. PubMed ID: 33928773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen.
    Soltani Hekmat A; Javanmardi K
    Biomed Res Int; 2021; 2021():7702863. PubMed ID: 34734086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombosis and thrombocytopaenia after ChAdOx1 nCoV-19 vaccination: a single UK centre experience.
    Bano F; Badugama B; Chandra D
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34257129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia.
    De Michele M; Iacobucci M; Chistolini A; Nicolini E; Pulcinelli F; Cerbelli B; Merenda E; Schiavo OG; Sbardella E; Berto I; Petraglia L; Caracciolo N; Chiara M; Truglia S; Toni D
    Nat Commun; 2021 Aug; 12(1):4663. PubMed ID: 34341358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination.
    Guan CY; Tsai SH; Fan JS; Lin YK; Kao CC
    Am J Emerg Med; 2022 Jan; 51():427.e3-427.e4. PubMed ID: 34274191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Takotsubo (stress) cardiomyopathy after ChAdOx1 nCoV-19 vaccination.
    Crane P; Wong C; Mehta N; Barlis P
    BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34625447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unusual Site of Deep Vein Thrombosis After mRNA Coronavirus Disease-2019 (COVID-19) Vaccination.
    Hasegawa T; Yazaki Y
    Circ J; 2022 Mar; 86(4):723. PubMed ID: 34840204
    [No Abstract]   [Full Text] [Related]  

  • 8. D-dimer driven deep vein thrombosis prophylaxis strategy for hospitalized patients with COVID-19.
    Stawiarski K; Loutoo A; Velardi L; Zarich S
    Thromb Res; 2021 May; 201():151-153. PubMed ID: 33862518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ChAdOx1 nCOV-19 vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis (CVST).
    Suresh P; Petchey W
    BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34135077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 and finding of vein thrombosis: can IMPROVE and IMPROVEDD scores predict COVID-19 outcomes?
    Greco S; Zenunaj G; Bonsi B; Bella A; Lopreiato M; Luciani F; Pedrini D; Vestita G; Dalla Nora E; Passaro A
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):2123-2130. PubMed ID: 33660832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of cerebral venous thrombosis and COVID-19 vaccination: possible causal effect or just chance?
    de Simone G; Stranges S; Gentile I
    Eur Heart J Cardiovasc Pharmacother; 2021 Jul; 7(4):e77-e78. PubMed ID: 33930114
    [No Abstract]   [Full Text] [Related]  

  • 12. Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase.
    Smadja DM; Yue QY; Chocron R; Sanchez O; Lillo-Le Louet A
    Eur Respir J; 2021 Jul; 58(1):. PubMed ID: 33863748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombocytopenia and Intracranial Venous Sinus Thrombosis after "COVID-19 Vaccine AstraZeneca" Exposure.
    Wolf ME; Luz B; Niehaus L; Bhogal P; Bäzner H; Henkes H
    J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33918932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased anticoagulation reduces proximal deep vein thrombosis in mechanically ventilated COVID-19 patients: Venous thrombosis prevention & COVID-19.
    Voicu S; Chousterman BG; Bonnin P; Deye N; Malissin I; Gall AL; Barthélémy R; Sutterlin L; Naim G; Mrad A; Pepin-Lehalleur A; Dorze ML; de Roquetaillade C; Ekhérian JM; Gayat E; Sidéris G; Mebazaa A; Mégarbane B
    J Infect; 2021 May; 82(5):186-230. PubMed ID: 33227338
    [No Abstract]   [Full Text] [Related]  

  • 15. Interrupting vaccination policies can greatly spread SARS-CoV-2 and enhance mortality from COVID-19 disease: The AstraZeneca case for France and Italy.
    Faranda D; Alberti T; Arutkin M; Lembo V; Lucarini V
    Chaos; 2021 Apr; 31(4):041105. PubMed ID: 34251248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The International Cerebral Venous Thrombosis Consortium report on cerebral venous thrombosis following vaccination against SARS-CoV-2.
    Muir KW; Perry RJ
    Eur J Neurol; 2021 Nov; 28(11):3543-3544. PubMed ID: 34462996
    [No Abstract]   [Full Text] [Related]  

  • 17. In adults, the Oxford/AstraZeneca vaccine had 70% efficacy against COVID-19 >14 d after the 2nd dose.
    Chagla Z
    Ann Intern Med; 2021 Mar; 174(3):JC29. PubMed ID: 33646835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alopecia areata after ChAdOx1 nCoV-19 vaccine (Oxford/AstraZeneca): a potential triggering factor?
    Essam R; Ehab R; Al-Razzaz R; Khater MW; Moustafa EA
    J Cosmet Dermatol; 2021 Dec; 20(12):3727-3729. PubMed ID: 34559937
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombosis of the palmar digital vein after Oxford-AstraZeneca COVID-19 vaccination.
    Chen YA; Huang HY; Wu SH; Huang TC
    Int J Dermatol; 2021 Nov; 60(11):e469-e471. PubMed ID: 34473841
    [No Abstract]   [Full Text] [Related]  

  • 20. Sustained COVID-19 vaccine willingness after safety concerns over the Oxford-AstraZeneca vaccine.
    Sønderskov KM; Dinesen PT; Østergaard SD
    Dan Med J; 2021 Mar; 68(5):. PubMed ID: 33870886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.